C B Lyde1. 1. Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, USA.
Abstract
BACKGROUND: Three pregnancies occurred in a cohort of 40 patients with Hansen disease during a 6-year period. There are few recent reports in the English literature that deal with pregnancy in patients with Hansen disease. These 3 cases are presented in the context of previously reported cohorts. OBSERVATIONS: In patient 1, symptoms of the disease appeared during pregnancy. In patient 2, reactivation vs reaction occurred during pregnancy in a previously treated patient. In patient 3, the fetus was exposed to 3 antimicrobial drugs during the first trimester. CONCLUSIONS: The pregnant state causes a relative decrease in cellular immunity. This decrease allows Mycobacterium leprae to proliferate, which may precipitate or worsen disease, leading to permanent nerve damage. Careful management of reactional states and treatment of patients with dapsone monotherapy can prevent this nerve damage. Infants are usually much less affected than mothers; however, selection of the mother's antimicrobial regimen must ensure adequate control of the bacteria while avoiding teratogenicity and in utero adverse effects.
BACKGROUND: Three pregnancies occurred in a cohort of 40 patients with Hansen disease during a 6-year period. There are few recent reports in the English literature that deal with pregnancy in patients with Hansen disease. These 3 cases are presented in the context of previously reported cohorts. OBSERVATIONS: In patient 1, symptoms of the disease appeared during pregnancy. In patient 2, reactivation vs reaction occurred during pregnancy in a previously treated patient. In patient 3, the fetus was exposed to 3 antimicrobial drugs during the first trimester. CONCLUSIONS: The pregnant state causes a relative decrease in cellular immunity. This decrease allows Mycobacterium leprae to proliferate, which may precipitate or worsen disease, leading to permanent nerve damage. Careful management of reactional states and treatment of patients with dapsone monotherapy can prevent this nerve damage. Infants are usually much less affected than mothers; however, selection of the mother's antimicrobial regimen must ensure adequate control of the bacteria while avoiding teratogenicity and in utero adverse effects.
Authors: Glendie Marcelin; Jerry R Aldridge; Susu Duan; Hazem E Ghoneim; Jerold Rehg; Henju Marjuki; Adrianus C M Boon; Jonathan A McCullers; Richard J Webby Journal: J Virol Date: 2011-08-24 Impact factor: 5.103
Authors: M A B Trindade; N Y S Valente; M I P Manini; M D F Takahashi; C F D Anjos; G Benard; B Naafs Journal: J Clin Microbiol Date: 2006-10-04 Impact factor: 5.948
Authors: Jessica K Fairley; Jose A Ferreira; Ana Laura Grossi de Oliveira; Thelma de Filippis; Maria Aparecida de Faria Grossi; Laura Pinheiro Chaves; Luiza Navarro Caldeira; Paola Souza Dos Santos; Rafaella Rodrigues Costa; Maria Cavallieri Diniz; Carolina Soares Duarte; Luiz Alberto Bomjardim Pôrto; Parminder S Suchdev; Deborah Aparecida Negrão-Corrêa; Fernanda do Carmo Magalhães; João Marcelo Peixoto Moreira; Adelino de Melo Freire Júnior; Mariana Costa Cerqueira; Uriel Kitron; Sandra Lyon Journal: Am J Trop Med Hyg Date: 2019-11 Impact factor: 2.345